Moderna files for U.S. authorization to use its COVID-19 vaccine in teens

Moderna files for U.S. authorization to use its COVID-19 vaccine in teens
Moderna Inc said on Thursday it has filed for U.S. authorization to use its COVID-19 vaccine in adolescents aged 12 through 17, potentially offering health-care providers and pediatricians an easier-to-store shot ahead of the return-to-school season in the fall.

drugmaker to seek regulatory nod for use of its vaccine in the age group, as the U.S. tries to vaccinate more young people.

Vaccinating children has been considered key to achieving "herd immunity" and while they mostly develop only mild COVID-19 symptoms or no symptoms, younger people still remain at risk of becoming seriously ill, and can spread the virus.

Moderna s vaccine is already being used in the United States, the European Union and Canada for anyone over 18. The drugmaker said it has also submitted applications to European and Canadian regulators seeking authorization for the shot s use in adolescents.

Last month, Moderna s two-shot vaccine was shown to be effective in adolescents aged 12-17 and showed no new or major safety problems in a clinical trial which evaluated the vaccine in 3,732 teenagers.

The U.S. has already authorized Pfizer Inc and German partner BioNTech SE s COVID-19 vaccine for use in children as young as 12.

More than 7 million teens have received at least one dose of the vaccine in the United States, according to the U.S. Centers for Disease Control and Prevention.
Read more on CTVnews
News Topics :
Similar Articles :
Top Stories
In a statement on Monday, the company said results from a clinical trial in the U.S. last month showed their two shot vaccine was effective in adolescents between the ages of...
BERLIN AP — The European Medicines Agency on Friday recommended that the use of the coronavirus vaccine made by Pfizer and BioNTech be expanded to children ages 12 to 15,...
Moderna MRNA said Thursday it has formally asked the U.S. Food & Drug Administration for emergency approval to use allow its coronavirus vaccine to be administered to teenagers over the...
Pfizer Inc and its German partner BioNTech SE on Friday asked U.S. regulators to allow the emergency use of their vaccine in adolescents aged 12 to 15. The vaccine is...
Top Stories
TORONTO Health Canada is reviewing a submission from Pfizer BioNTech to expand the use of its COVID 19 vaccine in children aged 12 and older. Health Canada said on...